2009 Breast Cancer Symposium Press Program Announced: Presscast on October 6 (12:00 PM EDT) to Feature Four Notable Studies

ASCO SIGN IN

Username:

Create an account

Why Be A Member?

Password:

Remember me

Forgot your username or password?

The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.

ASCO Home

Press Center

2009 Breast Cancer Symposium Press Program Announced: Presscast on October 6 (12:00 PM EDT) to Feature Four Notable Studies

FOR IMMEDIATE RELEASE:
September 22, 2009

CONTACT: Aaron Tallent
571-483-1371
aaron.tallent@asco.org

ALEXANDRIA, Va. – Key studies to be presented at the 2009 Breast Cancer Symposium will be highlighted in an embargoed presscast (press briefing via live webcast) on Tuesday, October 6 from 12:00-1:30 PM (EDT). The studies will address a range of critical issues in breast cancer, including the early detection, evaluation, treatment and management of the disease.

On the presscast, researchers will discuss four key studies, including:

Results from a large retrospective, population-based study evaluating mortality rates among women who received regular mammographic screening and those who did not.
Findings from the first population-based study to compare the rate of recurrence in women aged 50 or younger with ductal carcinoma in situ who underwent breast-conserving surgery and radiotherapy. While this treatment approach has resulted in substantial reductions in recurrence rates, there is concern that younger women may be at greater risk of recurrence.
A study evaluating the use of axillary ultrasound and fine-needle aspiration cytology prior to surgery to enable women scheduled for breast conservation surgery for early-stage breast cancer to avoid second surgeries.
A study exploring the use of a novel method of tissue analysis, called tissue microarrays, to identify the intrinsic subtype of a breast tumor and predict whether a woman with early-stage breast cancer that has spread to the lymph nodes will benefit from adjuvant paclitaxel (Taxol) chemotherapy.

This year’s symposium will take place from October 8 through October 10, 2009, at the San Francisco Marriott in California, and will feature more than 350 abstracts.

In addition to the presscast, a working newsroom will be available onsite at the meeting for reporters. Experts will be available for comment and perspective upon request.

Breast cancer is diagnosed in approximately 194,000 people in the U.S. every year. Six leading medical specialty societies are co-sponsoring the multidisciplinary symposium, including the American Society of Breast Disease, The American Society of Breast Surgeons, the American Society of Clinical Oncology, the American Society for Radiation Oncology, the National Consortium of Breast Centers and The Society of Surgical Oncology. Susan G. Komen for the Cure®, the world’s largest grassroots network of breast cancer survivors and advocates, is the primary supporter of the meeting.

Registration: To register to attend the meeting or participate in the presscast, visit www.asco.org/BCSPressKit09 or contact Kelly Powell at kelly.powell@asco.org or 571-483-1365.

# # #